Use of ascorbic acid in the genital area and corresponding medicinal preparations
December 22, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2918404 Method for the treatment of Herpes Simplex Method of treating atrophic vulvar dystrophy Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers Preparations for vaginal administration Method of curing or alleviating herpes infections and pharmaceutical compositions suitable therefor Method of treatment of pre-menstrual syndrome Treatment of herpes simplex Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom Protective additive to vaginal products and catamenials InventorsAssigneeApplicationNo. 172641 filed on 12/22/1993US Classes:514/474, Ascorbic acid or derivative (e.g., vitamin C, etc.)514/931, VENERAL DISEASE514/934, Virus514/967, VAGINAL514/969OINTMENT OR SALVE BASEExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/375A61K 009/06 AbstractA method of treating conditions of amine vaginitis, purulent vaginitis and dysplasia of the mouth of the uterus resulting from papilloma virus infection in the genital region of female animals by topically applying ascorbic acid to the affected region. The invention also provides a medicinal composition in the form of a an ointment or tablet containing about 3% to about 50% by weight of ascorbic acid and the balance a pharmaceutically acceptable ointment or tabletting carrier.Other References
| |
